Screener
Rani Therapeutics Holdings, Inc. RANI Q4 2025 Annual earnings
Reported March 26, 2026 · After market close
Revenue$1.5MMiss by $3.5M
EPS-$0.07Miss by $0.04
Revenue estimate$5.0M
EPS estimate-$0.03
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.3M
EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Rani Therapeutics Holdings, Inc. report Q4 2025 earnings?
- Rani Therapeutics Holdings, Inc. (RANI) reported Q4 2025 earnings on March 26, 2026 after market close.
- What were Rani Therapeutics Holdings, Inc.'s Q4 2025 revenue and EPS?
- Rani Therapeutics Holdings, Inc. reported revenue of $1.5M and eps of $-0.07 for Q4 2025.
- Did Rani Therapeutics Holdings, Inc. beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $5.0M by $3.5M. EPS missed the consensus estimate of $-0.03 by $0.04.
- How did Rani Therapeutics Holdings, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 42.1% from $1.0M a year earlier and eps grew 74.1% from $-0.27.
- Where can I find Rani Therapeutics Holdings, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-126240) and the 10-K periodic report (0001193125-26-126417) directly on SEC EDGAR. The filing index links above go to sec.gov.
